We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current S66 market cap is 21.61M. The company's latest EPS is AUD 0.0055 and P/E is 29.09.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 40.3M | 28.01M | 23.86M | 24.86M | 26.22M |
| Operating Income | -343k | -6.96M | -1.02M | -3.32M | 1.07M |
| Net Income | -349k | -7.88M | -696k | -4M | 747k |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 54.72M | 43.32M | 43.44M | 42.23M | 42.82M |
| Total Liabilities | 10.22M | 7.13M | 8.04M | 8.97M | 9.31M |
| Total Equity | 44.5M | 36.19M | 35.41M | 33.26M | 33.51M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.02M | 332k | 534k | 1.88M | -316k |
| Investing | -3.63M | -7.53M | -3.24M | -3.23M | -137k |
| Financing | 26.63M | -2.08M | -169k | -54k | -371k |
| Market Cap | 21.61M |
| Price to Earnings Ratio | 29.09 |
| Price to Sales Ratio | 0.82 |
| Price to Cash Ratio | 10 |
| Price to Book Ratio | 0.64 |
| Dividend Yield | - |
| Shares Outstanding | 135.08M |
| Average Volume (1 week) | 3.5k |
| Average Volume (1 Month) | 7.46k |
| 52 Week Change | 33.33% |
| 52 Week High | 0.1875 |
| 52 Week Low | 0.105 |
| Spread (Intraday) | 0.03 (15.63%) |
| Company Name | Star Combo Pharma Limited |
| Address |
171-177 woodpark road sydney, new south wales 2164 |
| Website | https://www.starcombo.com.au |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
